Circulation: Genomic and Precision Medicine, 2023
Combining Polygenic and Proteomic Risk Scores With Clinical Risk Factors to Improve Performance for Diagnosing Absence of Coronary Artery Disease in Patients With de novo Chest Pain

Møller P., Rohde P., Dahl J. et al.

Circulation: Heart Failure, 2023
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study

Buckley L., Agha A., Dorbala P. et al.

Journal of Clinical Medicine, 2023
Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19

Dutsch A., Uhlig C., Bock M. et al.

Journal of Dermatological Science, 2023
Bath-psoralen plus UVA therapy changes inflammatory proteomic signatures for systemic effects beyond the skin

Kanayama Y., Ikumi K., Sakurai M. et al.

Journal of Functional Foods, 2023
High-parameter immune profiling and subjective health assessment of the immunomodulatory effects of paramylon-rich Euglena gracilis EOD-1: A randomized, double-blind, placebo-controlled, parallel-group study

Kawano T., Miura A., Naito J. et al.

Science Advances, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

Rejeski K., Perez A., Iacoboni G. et al.

Journal of Proteome Research, 2023
IL18R1-Related Molecules as Biomarkers for Asthma Severity and Prognostic Markers for Idiopathic Pulmonary Fibrosis

Lin K., Wang T., Tang Q. et al.

International Journal of Cardiology, 2023
Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D

Baumhove L., Bomer N., Tromp J. et al.

Aging Cell, 2023
Proteomic architecture of frailty across the spectrum of cardiovascular disease

Perry A., Zhao S., Gajjar P. et al.

Molecular Psychiatry, 2023
Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders

Lizano P., Pong S., Santarriaga S. et al.

Genome Medicine, 2023
Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome

Sun J., Zhao J., Jiang F. et al.

Nature Aging, 2023
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease

Pereira J., Kumar A., Hall S. et al.

International Journal of Molecular Sciences, 2023
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease

Wärme J., Sundqvist M., Hjort M. et al.

European Urology, 2023
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer

Strandgaard T., Nordentoft I., Birkenkamp-Demtröder K. et al.

BMJ Open, 2023
Plasma type I collagen α1 chain in relation to coronary artery disease: findings from a prospective population-based cohort and an acute myocardial infarction prospective cohort in Sweden

Hammaréus F., Nilsson L., Ong K. et al.

Frontiers in Immunology, 2023
Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study

Yuan S., Miao Y., Ruan X. et al.

Journal of Clinical Investigation, 2023
Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction

Spencer R., Maksym K., Hecher K. et al.

JID Innovations, 2023
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream

Howell M., Kuo F., Rumberger B. et al.

Nature Communications, 2023
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

del Campo M., Vermunt L., Peeters C. et al.

mSystems, 2023
Abnormal blood microbiota profiles are associated with inflammation and immune restoration in HIV/AIDS individuals

Guo X., Wang Z., Qu M. et al.